Skip to main content

Articles

Recent Articles

How to Maximize Patient Recruitment in Oncology Trials
Articles  —  6 June Jun 2017
Oncology

How to Maximize Patient Recruitment in Oncology Trials

Read More about How to Maximize Patient Recruitment in Oncology Trials
Lifestyle intervention improves GlycA a novel biomarker of inflammatory CVD among obese, prediabetic, adolescent Latinos
Articles  —  1 June Jun 2017
Oncology

Lifestyle intervention improves GlycA a novel biomarker of inflammatory CVD among obese, prediabetic, adolescent Latinos

Read More about Lifestyle intervention improves GlycA a novel biomarker of inflammatory CVD among obese, prediabetic, adolescent Latinos
Don’t know activity from ADAM(TS13)? The first LC-MS/MS assay for measuring activity of von Willebrand factor cleaving protease
Articles  —  1 June Jun 2017
Oncology

Don’t know activity from ADAM(TS13)? The first LC-MS/MS assay for measuring activity of von Willebrand factor cleaving protease

Read More about Don’t know activity from ADAM(TS13)? The first LC-MS/MS assay for measuring activity of von Willebrand factor cleaving protease
There are no absolutes, particularly in protein quantification
Articles  —  1 June Jun 2017
Oncology

There are no absolutes, particularly in protein quantification

Read More about There are no absolutes, particularly in protein quantification
Improved recovery of beta-hemolytic streptococcus species from group A streptococcus cultures using WASP® instrumentation in streak only mode
Articles  —  1 June Jun 2017
Oncology

Improved recovery of beta-hemolytic streptococcus species from group A streptococcus cultures using WASP® instrumentation in streak only mode

Read More about Improved recovery of beta-hemolytic streptococcus species from group A streptococcus cultures using WASP® instrumentation in streak only mode
Performance of new MALDI-TOF database for identification of mycobacterium and nocardia
Articles  —  1 June Jun 2017
Oncology

Performance of new MALDI-TOF database for identification of mycobacterium and nocardia

Read More about Performance of new MALDI-TOF database for identification of mycobacterium and nocardia
Serial genome-wide sequencing of cell-free DNA (cfDNA) by assays used in non-invasive prenatal testing (NIPT) to identify copy number alterations (CNAs) associated with immunotherapy response
Articles  —  1 June Jun 2017
Oncology

Serial genome-wide sequencing of cell-free DNA (cfDNA) by assays used in non-invasive prenatal testing (NIPT) to identify copy number alterations (CNAs) associated with immunotherapy response

Read More about Serial genome-wide sequencing of cell-free DNA (cfDNA) by assays used in non-invasive prenatal testing (NIPT) to identify copy number alterations (CNAs) associated with immunotherapy response
Assessment of Abuse Liability of Brain-Penetrant Compounds: Regulatory Environment, Challenges and Opportunities in View of the Current Opioid Epidemic
Articles  —  12 May May 2017
Oncology

Assessment of Abuse Liability of Brain-Penetrant Compounds: Regulatory Environment, Challenges and Opportunities in View of the Current Opioid Epidemic

Read More about Assessment of Abuse Liability of Brain-Penetrant Compounds: Regulatory Environment, Challenges and Opportunities in View of the Current Opioid Epidemic
Assessment of Abuse Liability of Brain-Penetrant Compounds: Regulatory Environment, Challenges and Opportunities in View of the Current Opioid Epidemic
Articles  —  12 May May 2017
Oncology

Assessment of Abuse Liability of Brain-Penetrant Compounds: Regulatory Environment, Challenges and Opportunities in View of the Current Opioid Epidemic

Read More about Assessment of Abuse Liability of Brain-Penetrant Compounds: Regulatory Environment, Challenges and Opportunities in View of the Current Opioid Epidemic
Identifying needs of laboratory professionals regarding factor VIII/IX activity assays
Articles  —  4 May May 2017
Oncology

Identifying needs of laboratory professionals regarding factor VIII/IX activity assays

Read More about Identifying needs of laboratory professionals regarding factor VIII/IX activity assays
The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue
Articles  —  1 May May 2017
Oncology

The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue

Read More about The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue
Over a half million noninvasive prenatal tests: a clinical laboratory experience (ACOG)
Articles  —  1 May May 2017
Oncology

Over a half million noninvasive prenatal tests: a clinical laboratory experience (ACOG)

Read More about Over a half million noninvasive prenatal tests: a clinical laboratory experience (ACOG)